LTFS
SAGE

Ladenburg Thalmann Financial Services’s Sage Therapeutics SAGE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$56K Buy
771
+221
+40% +$27.2K ﹤0.01% 3450
2019
Q3 		$77K Sell
550
-1,372
-71% -$230K ﹤0.01% 3129
2019
Q2 		$351K Buy
1,922
+1,522
+381% +$260K ﹤0.01% 2015
2019
Q1 		$63K Buy
400
+66
+20% +$9.56K ﹤0.01% 3243
2018
Q4 		$32K Sell
334
-234
-41% -$26.8K ﹤0.01% 3570
2018
Q3 		$81K Buy
568
+110
+24% +$17K ﹤0.01% 2971
2018
Q2 		$73K Hold
458
– – ﹤0.01% 2987
2018
Q1 		$73K Buy
458
+76
+20% +$12.9K ﹤0.01% 2987
2017
Q4 		$63K Buy
382
+364
+2,022% +$35.3K ﹤0.01% 3069
2017
Q3 		$1K Buy
18
+7
+64% +$550 ﹤0.01% 4817
2017
Q2 		$1K Hold
11
– – ﹤0.01% 4758
2017
Q1 		$1K Hold
11
– – ﹤0.01% 4735
2016
Q4 		$1K Hold
11
– – ﹤0.01% 4694
2016
Q3 		$1K Sell
11
-5
-31% -$204 ﹤0.01% 4645
2016
Q2 		$0 Hold
16
– – ﹤0.01% 4824
2016
Q1 		$1K Sell
16
-18
-53% -$634 ﹤0.01% 4549
2015
Q4 		$2K Buy
34
+15
+79% +$743 ﹤0.01% 4375
2015
Q3 		$1K Hold
19
– – ﹤0.01% 4444
2015
Q2 		$1K Buy
+19
New +$1.22K ﹤0.01% 4517

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SAGE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Sage Therapeutics (SAGE) stake by 40% in Q4 2019, buying an estimated $27.2K and bringing the position to 771 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #3450.

Ladenburg Thalmann Financial Services first reported a position in SAGE in Q2 2015 and has held it in 19 quarters since. The position peaked at $351K in Q2 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 771 shares of Sage Therapeutics worth $56K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 221 Sage Therapeutics shares in Q4 2019, an estimated $27.2K.
  • Sage Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3450 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Sage Therapeutics in Q2 2015 and has held it in 19 quarters since.
  • Ladenburg Thalmann Financial Services's Sage Therapeutics position peaked at $351K in Q2 2019.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.